Compare with BAFNA PHARM. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZOTA HEALTH CARE vs BAFNA PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ZOTA HEALTH CARE BAFNA PHARMA ZOTA HEALTH CARE/
BAFNA PHARMA
 
P/E (TTM) x 213.4 41.4 515.0% View Chart
P/BV x 15.6 5.8 266.8% View Chart
Dividend Yield % 0.2 0.0 -  

Financials

 ZOTA HEALTH CARE   BAFNA PHARMA
EQUITY SHARE DATA
    ZOTA HEALTH CARE
Mar-21
BAFNA PHARMA
Mar-21
ZOTA HEALTH CARE/
BAFNA PHARMA
5-Yr Chart
Click to enlarge
High Rs175196 89.3%   
Low Rs1379 1,475.8%   
Sales per share (Unadj.) Rs43.530.1 144.5%  
Earnings per share (Unadj.) Rs-0.12.5 -3.5%  
Cash flow per share (Unadj.) Rs1.24.4 27.7%  
Dividends per share (Unadj.) Rs1.000-  
Avg Dividend yield %0.60-  
Book value per share (Unadj.) Rs27.024.0 112.5%  
Shares outstanding (eoy) m24.5623.66 103.8%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x3.63.4 105.3%   
Avg P/E ratio x-1,834.741.7 -4,403.4%  
P/CF ratio (eoy) x129.623.6 549.9%  
Price / Book Value ratio x5.84.3 135.3%  
Dividend payout %-1,175.10-   
Avg Mkt Cap Rs m3,8342,428 157.9%   
No. of employees `000NANA-   
Total wages/salary Rs m86120 71.4%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m1,068712 149.9%  
Other income Rs m137 174.4%   
Total revenues Rs m1,081720 150.2%   
Gross profit Rs m16103 15.6%  
Depreciation Rs m3245 70.8%   
Interest Rs m17 14.8%   
Profit before tax Rs m-458 -6.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-20-   
Profit after tax Rs m-258 -3.6%  
Gross profit margin %1.514.5 10.4%  
Effective tax rate %42.90-   
Net profit margin %-0.28.2 -2.4%  
BALANCE SHEET DATA
Current assets Rs m612497 123.2%   
Current liabilities Rs m182243 75.0%   
Net working cap to sales %40.235.6 113.0%  
Current ratio x3.42.0 164.3%  
Inventory Days Days350-  
Debtors Days Days983490 200.7%  
Net fixed assets Rs m243368 66.0%   
Share capital Rs m246237 103.8%   
"Free" reserves Rs m417331 126.0%   
Net worth Rs m663568 116.8%   
Long term debt Rs m053 0.0%   
Total assets Rs m855865 98.9%  
Interest coverage x-2.38.9 -26.3%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x1.20.8 151.7%   
Return on assets %-0.17.6 -1.5%  
Return on equity %-0.310.3 -3.1%  
Return on capital %-0.410.6 -3.6%  
Exports to sales %20.60-   
Imports to sales %05.9 0.0%   
Exports (fob) Rs m220NA-   
Imports (cif) Rs mNA42 0.0%   
Fx inflow Rs m220347 63.4%   
Fx outflow Rs m1242 27.5%   
Net fx Rs m209305 68.4%   
CASH FLOW
From Operations Rs m-9-136 6.5%  
From Investments Rs m38-53 -71.5%  
From Financial Activity Rs m-24123 -19.7%  
Net Cashflow Rs m5-67 -7.7%  

Share Holding

Indian Promoters % 68.1 90.4 75.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.3 0.0 -  
FIIs % 0.1 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 31.9 9.6 332.4%  
Shareholders   7,256 8,068 89.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ZOTA HEALTH CARE With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    



Today's Market

Sensex Plunges 656 Points, Nifty Ends Below 18,000; Oil & Gas, Metal Stocks Outperform(Closing)

Indian share markets witnessed negative trading activity throughout the day today and ended on a weak note.

Related Views on News

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

More Views on News

Most Popular

India's Best Semiconductor Stocks(Views On News)

Jan 7, 2022

Modern wars are fought with semiconductors. India's best semiconductor stocks have big tailwinds from defence and manufacturing.

10 Indian Companies with the Fastest Growth in Dividend Payouts...(Views On News)

Jan 10, 2022

These companies have been consistently paying higher dividends for several years.

Tata Steel vs SAIL: Which Stock is Better?(Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Looking for Consistent Compounding Stocks? Here's a Watchlist for You(Views On News)

Jan 6, 2022

These companies have generated mind boggling returns for investors over the years.

Watch Out for these 4 Indian Companies Betting Big on EV Supply Chain(Views On News)

Jan 11, 2022

The upside in supply chain players could be huge but a delay in the transition to EVs, or any policy related hiccups could end the momentum.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ZOTA HEALTH CARE SHARE PRICE


Jan 19, 2022 (Close)

TRACK ZOTA HEALTH CARE

  • Track your investment in ZOTA HEALTH CARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ZOTA HEALTH CARE

ZOTA HEALTH CARE 8-QTR ANALYSIS

COMPARE ZOTA HEALTH CARE WITH

MARKET STATS